G.J. Ossenkoppele

5.4k total citations
84 papers, 3.3k citations indexed

About

G.J. Ossenkoppele is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, G.J. Ossenkoppele has authored 84 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 19 papers in Pathology and Forensic Medicine and 19 papers in Oncology. Recurrent topics in G.J. Ossenkoppele's work include Acute Myeloid Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (19 papers) and Acute Lymphoblastic Leukemia research (14 papers). G.J. Ossenkoppele is often cited by papers focused on Acute Myeloid Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (19 papers) and Acute Lymphoblastic Leukemia research (14 papers). G.J. Ossenkoppele collaborates with scholars based in Netherlands, United States and United Kingdom. G.J. Ossenkoppele's co-authors include Arjan A. van de Loosdrecht, N Feller, Bob Löwenberg, Gerrit Jan Schuurhuis, Peter C. Huijgens, Jeroen J. W. M. Janssen, Pieter Sonneveld, G. Verhoef, Martine E.D. Chamuleau and Angèle Kelder and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

G.J. Ossenkoppele

78 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.J. Ossenkoppele Netherlands 34 1.6k 1.1k 812 783 677 84 3.3k
Lee‐Yung Shih Taiwan 30 1.7k 1.1× 663 0.6× 661 0.8× 1.2k 1.5× 776 1.1× 195 3.6k
Stefan Hohaus Italy 39 1.5k 1.0× 1.4k 1.2× 1.0k 1.3× 1.4k 1.8× 591 0.9× 167 4.2k
Sang Kyun Sohn South Korea 28 1.4k 0.9× 723 0.6× 391 0.5× 600 0.8× 567 0.8× 191 2.7k
Kazimierz Kuliczkowski Poland 29 1.2k 0.8× 1.2k 1.1× 794 1.0× 1.1k 1.4× 1.1k 1.6× 202 3.5k
Yago Nieto United States 34 1.9k 1.2× 1.7k 1.5× 594 0.7× 859 1.1× 644 1.0× 242 4.0k
Anna Porwit‐MacDonald Sweden 30 1.1k 0.7× 604 0.5× 938 1.2× 610 0.8× 631 0.9× 50 2.7k
Hyeoung‐Joon Kim South Korea 29 1.4k 0.9× 909 0.8× 436 0.5× 1.0k 1.3× 524 0.8× 213 3.0k
Anna Marina Liberati Italy 31 1.3k 0.8× 1.9k 1.7× 1.3k 1.6× 1.1k 1.4× 689 1.0× 148 3.8k
Julio Delgado Spain 35 1.1k 0.7× 1.0k 0.9× 1.3k 1.7× 647 0.8× 1.6k 2.4× 195 3.6k
Krzysztof Warzocha Poland 26 614 0.4× 672 0.6× 1.1k 1.4× 518 0.7× 999 1.5× 169 2.6k

Countries citing papers authored by G.J. Ossenkoppele

Since Specialization
Citations

This map shows the geographic impact of G.J. Ossenkoppele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.J. Ossenkoppele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.J. Ossenkoppele more than expected).

Fields of papers citing papers by G.J. Ossenkoppele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.J. Ossenkoppele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.J. Ossenkoppele. The network helps show where G.J. Ossenkoppele may publish in the future.

Co-authorship network of co-authors of G.J. Ossenkoppele

This figure shows the co-authorship network connecting the top 25 collaborators of G.J. Ossenkoppele. A scholar is included among the top collaborators of G.J. Ossenkoppele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.J. Ossenkoppele. G.J. Ossenkoppele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeijlemaker, Wendelien, Angèle Kelder, Yvonne J.M Oussoren-Brockhoff, et al.. (2015). A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia. Leukemia. 30(2). 439–446. 88 indexed citations
2.
Alhan, Canan, Theresia M. Westers, Eline M.P. Cremers, et al.. (2015). The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system. Leukemia. 30(3). 658–665. 27 indexed citations
3.
Poel, Marjolein van der, Wubbo J. Mulder, G.J. Ossenkoppele, et al.. (2015). Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study. Annals of Hematology. 94(8). 1373–1379. 11 indexed citations
4.
Ossenkoppele, G.J., et al.. (2014). Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index. European Journal of Cancer. 50(18). 3198–3205. 18 indexed citations
5.
Chamuleau, Martine E.D., G.J. Ossenkoppele, Anna van Rhenen, et al.. (2011). High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2. Leukemia Research. 35(6). 741–749. 33 indexed citations
6.
Canals, Carmen, H. Schouten, Arnon Nagler, et al.. (2009). Allogeneic stem cell transplantation as salvage therapy in patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem cell transplantation. An analysis of the EBMT Registry. Bone Marrow Transplantation. 43. 2 indexed citations
7.
Luijn, Marvin M. van, Martine E.D. Chamuleau, James A. Thompson, et al.. (2009). Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses. Haematologica. 95(3). 485–493. 21 indexed citations
8.
Galen, Joost C. van, Jettie J.F. Muris, W Vos, et al.. (2008). Expression of TNF‐receptor associated factor 2 correlates with poor progression‐free survival time in ABC‐like primary nodal diffuse large B‐cell lymphomas. Histopathology. 52(5). 578–584. 6 indexed citations
9.
10.
Chamuleau, Martine E.D., G.J. Ossenkoppele, & Arjan A. van de Loosdrecht. (2006). MHC class II molecules in tumour immunology: Prognostic marker and target for immune modulation. Immunobiology. 211(6-8). 619–625. 36 indexed citations
11.
Muris, Jettie J.F., et al.. (2005). Profiling of caspase signalling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas (DLBCL). Annals of Oncology. 16. 73–73. 1 indexed citations
12.
Muris, Jettie J.F., C J Meijer, Saskia A.G.M. Cillessen, et al.. (2003). Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas. Leukemia. 18(3). 589–596. 77 indexed citations
13.
Stijn, Amber van, Alice Kok, N Feller, et al.. (2003). A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia. Leukemia. 17(4). 780–786. 22 indexed citations
14.
Vries, Elisabeth G.E. de, et al.. (2000). P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.. PubMed. 6(8). 3205–14. 84 indexed citations
15.
Groot, C.A. Uyl-de, et al.. (1999). Stem Cell Transplantations in Patients with Malignant Lymphoma: Costs in a Dutch University Hospital in the Period 1984-1995. Journal of Hematotherapy & Stem Cell Research. 8(6). 619–625. 4 indexed citations
16.
Broxterman, H J, Pieter Sonneveld, R. Pieters, et al.. (1999). Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?. Leukemia. 13(2). 258–265. 34 indexed citations
17.
Thijsen, S. F. T., et al.. (1999). Chronic myeloid leukemia from basics to bedside. Leukemia. 13(11). 1646–1674. 45 indexed citations
18.
19.
Huijgens, Peter C., Andries R. Jonkhoff, O. S. Hoekstra, G.J. Ossenkoppele, & G. J. J. Teule. (1993). Therapeutic potential of intravenous 67‐gallium in non‐Hodgkin's lymphoma. European Journal Of Haematology. 51(4). 206–208. 8 indexed citations
20.
Heimans, J.J., P. Wijermans, CH Polman, et al.. (1990). Longterm meningeal involvement as the only clinical manifestation of low grade malignant non-Hodgkin's lymphoma. Journal of Neuro-Oncology. 9(3). 275–277. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lee‐Yung Shih Breakdown of academic impact, for papers by Stefan Hohaus Breakdown of academic impact, for papers by Sang Kyun Sohn Breakdown of academic impact, for papers by Kazimierz Kuliczkowski Breakdown of academic impact, for papers by Yago Nieto Breakdown of academic impact, for papers by Anna Porwit‐MacDonald Breakdown of academic impact, for papers by Hyeoung‐Joon Kim Breakdown of academic impact, for papers by Anna Marina Liberati Breakdown of academic impact, for papers by Julio Delgado Breakdown of academic impact, for papers by Krzysztof Warzocha
Rankless by CCL
2026